CorMedix

CRMD • NASDAQ • Stock Fundamentals

CorMedix is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph Todisco, with a market cap of $648.8M.

Market Cap$648.8M

Employees82.0

CEOJoseph Todisco

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about CorMedix

CorMedix (CRMD) has a market capitalization of $648.8M and trades on NASDAQ.

CorMedix has approximately 82 employees.